These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21171667)

  • 1. Change in hematologic indices over time in pediatric inflammatory bowel disease treated with azathioprine.
    Soman S; Ashok D; Connolly SA; Cordell SJ; Taylor CJ; Campbell DI
    Drugs R D; 2010; 10(4):213-7. PubMed ID: 21171667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte mean corpuscular volume as a surrogate marker for 6-thioguanine nucleotide concentration monitoring in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine.
    Thomas CW; Lowry PW; Franklin CL; Weaver AL; Myhre GM; Mays DC; Tremaine WJ; Lipsky JJ; Sandborn WJ
    Inflamm Bowel Dis; 2003 Jul; 9(4):237-45. PubMed ID: 12902847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does lymphopenia or macrocytosis reflect 6-thioguanine levels in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine?
    Heerasing NM; Ng JF; Dowling D
    Intern Med J; 2016 Apr; 46(4):465-9. PubMed ID: 26425841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effect of NUDT15 R139C on hematologic indices in inflammatory bowel disease patients treated with thiopurine.
    Akiyama S; Matsuoka K; Fukuda K; Hamada S; Shimizu M; Nanki K; Mizuno S; Kiyohara H; Arai M; Sugimoto S; Iwao Y; Ogata H; Hisamatsu T; Naganuma M; Motobayashi M; Suzuki K; Takenaka K; Fujii T; Saito E; Nagahori M; Ohtsuka K; Mochizuki M; Watanabe M; Hashiguchi M; Kanai T
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1751-1757. PubMed ID: 31045285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience.
    Connell WR; Kamm MA; Ritchie JK; Lennard-Jones JE
    Gut; 1993 Aug; 34(8):1081-5. PubMed ID: 8174958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression.
    Zelinkova Z; Derijks LJ; Stokkers PC; Vogels EW; van Kampen AH; Curvers WL; Cohn D; van Deventer SJ; Hommes DW
    Clin Gastroenterol Hepatol; 2006 Jan; 4(1):44-9. PubMed ID: 16431304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease.
    Lowry PW; Franklin CL; Weaver AL; Pike MG; Mays DC; Tremaine WJ; Lipsky JJ; Sandborn WJ
    Gut; 2001 Nov; 49(5):665-70. PubMed ID: 11600469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Genetic Polymorphisms on 6-Thioguanine Nucleotide Levels and Toxicity in Pediatric Patients with IBD Treated with Azathioprine.
    Lee MN; Kang B; Choi SY; Kim MJ; Woo SY; Kim JW; Choe YH; Lee SY
    Inflamm Bowel Dis; 2015 Dec; 21(12):2897-908. PubMed ID: 26332308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjustment of azathioprine dose should be based on a lower 6-TGN target level to avoid leucopenia in NUDT15 intermediate metabolisers.
    Kang B; Kim TJ; Choi J; Baek SY; Ahn S; Choi R; Lee SY; Choe YH
    Aliment Pharmacol Ther; 2020 Aug; 52(3):459-470. PubMed ID: 32598049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mean Corpuscular Volume to White Blood Cell Ratio for Thiopurine Monitoring in Pediatric Inflammatory Bowel Disease.
    Kandavel P; Eder SJ; Newman NE; Waljee AK; Whitfield EP; Adler J
    J Pediatr Gastroenterol Nutr; 2019 Jul; 69(1):88-94. PubMed ID: 30747813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of thiopurine methyltransferase activity in inflammatory bowel disease patients maintained on low-dose azathioprine.
    Campbell S; Kingstone K; Ghosh S
    Aliment Pharmacol Ther; 2002 Mar; 16(3):389-98. PubMed ID: 11876691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azathioprine: when less is more.
    Duley JA; Florin TH
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1317-9. PubMed ID: 18853992
    [No Abstract]   [Full Text] [Related]  

  • 13. The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients.
    Kurzawski M; Dziewanowski K; Gawrońska-Szklarz B; Domański L; Droździk M
    Ther Drug Monit; 2005 Aug; 27(4):435-41. PubMed ID: 16044099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease.
    Ansari A; Hassan C; Duley J; Marinaki A; Shobowale-Bakre EM; Seed P; Meenan J; Yim A; Sanderson J
    Aliment Pharmacol Ther; 2002 Oct; 16(10):1743-50. PubMed ID: 12269967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective case series analysis of patients with inflammatory bowel disease on azathioprine. A district general hospital experience.
    Khan ZH; Mayberry JF; Spiers N; Wicks AC
    Digestion; 2000; 62(4):249-54. PubMed ID: 11070408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The frequency and the course of the adverse effects of azathioprine/6-mercaptopurine treatment in patients with inflammatory bowel disease].
    Kim JH; Cheon JH; Kim WH
    Korean J Gastroenterol; 2008 May; 51(5):291-7. PubMed ID: 18516013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Prospective Study Evaluating Metabolic Capacity of Thiopurine and Associated Adverse Reactions in Japanese Patients with Inflammatory Bowel Disease (IBD).
    Odahara S; Uchiyama K; Kubota T; Ito Z; Takami S; Kobayashi H; Saito K; Koido S; Ohkusa T
    PLoS One; 2015; 10(9):e0137798. PubMed ID: 26360046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics of thiopurine therapy in paediatric IBD patients.
    De Ridder L; Van Dieren JM; Van Deventer HJ; Stokkers PC; Van der Woude JC; Van Vuuren AJ; Benninga MA; Escher JC; Hommes DW
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1137-41. PubMed ID: 16611274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of chronic inflammatory bowel diseases with azathioprine, 6-mercaptopurine and 6-thioguanine. Clinico-pharmacologic aspects].
    Schwab M; Herrlinger K; Schaeffeler E; Stange EF
    Dtsch Med Wochenschr; 2003 Feb; 128(8):378-85. PubMed ID: 12594624
    [No Abstract]   [Full Text] [Related]  

  • 20. Monitoring of azathioprine/6-mercaptopurine treatment in children with IBD is not necessary.
    Griffiths AM
    Inflamm Bowel Dis; 2003 Nov; 9(6):389-91; discussion 392-3. PubMed ID: 14671489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.